Our bioinformatic analysis of both databases clearly indicated increased expression of ITGA3 in GBM samples and in GBM patients with wild-type IDH1R132, whereas our previous analysis found decreased expression in 3D cultures [14]. The gene discussed is ITGA3; the disease is glioblastoma.